CDRE vs ICFI

CDRE exhibits a strong deterministic health profile with a Piotroski F-Score of 7/9 and excellent liquidity (Current Ratio 3.50), yet it faces severe valuation and growth headwinds. The stock is trading at a significant premium to its Graham Number ($13.15) and Intrinsic Value ($7.14), while simultaneously experiencing negative YoY revenue (-5.00%) and earnings growth (-13.30%). This fundamental deterioration is compounded by aggressive insider selling totaling $61.87M by the CEO, CFO, and President. Despite a 'strong_buy' analyst consensus, the technical trend is 0/100 and the price is hovering near its 52-week low, suggesting a disconnect between analyst targets and market reality.

ICFI presents as a classic value trap; while the Piotroski F-Score of 4/9 indicates stable health and the current price sits below the Graham Number ($79.23), the fundamental growth trajectory is severely compromised. Revenue and earnings are contracting by double digits (-10.6% and -27.4% YoY, respectively), and the technical trend is completely bearish (0/100). Despite a low Forward P/E of 8.82, the disconnect between analyst price targets ($105.25) and the actual price action suggests a failure of the growth thesis.